Generics - Gastro-intestinals, Licensing

Filter

Popular Filters

Par Pharma acquires Handa's ANDA for generic Dexilant

23-04-2012

USA-based Par Pharmaceutical (NYSE: PRX) has entered into an exclusive acquisition and license agreement…

DexilantGastro-intestinalsGenericsHanda PharmaceuticalsLicensingNorth AmericaPar PharmaceuticalsTakeda Pharmaceuticals

Back to top